A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-PTX) plus gemcitabine (GEM) significantly improved overall survival in patients with metastatic pancreatic adenocarcinoma. Anti-tumor synergy between GEM and nab-PTX was recently demonstrated in a mouse model. We planned to assess the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachihara, Motoko, Kiriu, Tatsunori, Hata, Akito, Hatakeyama, Yukihisa, Nakata, Kyosuke, Nagano, Tatsuya, Yamamoto, Masatsugu, Kobayashi, Kazuyuki, Ohnishi, Hisashi, Katakami, Nobuyuki, Nishimura, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681155/
https://www.ncbi.nlm.nih.gov/pubmed/31534366
http://dx.doi.org/10.2147/CMAR.S208224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681155/
https://www.ncbi.nlm.nih.gov/pubmed/31534366
http://dx.doi.org/10.2147/CMAR.S208224

Ejemplares similares